These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 8083999

  • 1. trans activation by the full-length E2 proteins of human papillomavirus type 16 and bovine papillomavirus type 1 in vitro and in vivo: cooperation with activation domains of cellular transcription factors.
    Ushikai M, Lace MJ, Yamakawa Y, Kono M, Anson J, Ishiji T, Parkkinen S, Wicker N, Valentine ME, Davidson I.
    J Virol; 1994 Oct; 68(10):6655-66. PubMed ID: 8083999
    [Abstract] [Full Text] [Related]

  • 2. Bovine papillomavirus type 1 E2 transcriptional regulators directly bind two cellular transcription factors, TFIID and TFIIB.
    Rank NM, Lambert PF.
    J Virol; 1995 Oct; 69(10):6323-34. PubMed ID: 7666533
    [Abstract] [Full Text] [Related]

  • 3. Transcriptional activity among high and low risk human papillomavirus E2 proteins correlates with E2 DNA binding.
    Hou SY, Wu SY, Chiang CM.
    J Biol Chem; 2002 Nov 22; 277(47):45619-29. PubMed ID: 12239214
    [Abstract] [Full Text] [Related]

  • 4. DNA structure and flexibility in the sequence-specific binding of papillomavirus E2 proteins.
    Hines CS, Meghoo C, Shetty S, Biburger M, Brenowitz M, Hegde RS.
    J Mol Biol; 1998 Mar 06; 276(4):809-18. PubMed ID: 9500925
    [Abstract] [Full Text] [Related]

  • 5. The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID.
    Tan SH, Leong LE, Walker PA, Bernard HU.
    J Virol; 1994 Oct 06; 68(10):6411-20. PubMed ID: 8083979
    [Abstract] [Full Text] [Related]

  • 6. Suppression of cellular proliferation by the papillomavirus E2 protein.
    Dowhanick JJ, McBride AA, Howley PM.
    J Virol; 1995 Dec 06; 69(12):7791-9. PubMed ID: 7494290
    [Abstract] [Full Text] [Related]

  • 7. Characterization of the human papillomavirus E2 protein: evidence of trans-activation and trans-repression in cervical keratinocytes.
    Bouvard V, Storey A, Pim D, Banks L.
    EMBO J; 1994 Nov 15; 13(22):5451-9. PubMed ID: 7957111
    [Abstract] [Full Text] [Related]

  • 8. Sequence-specific and general transcriptional activation by the bovine papillomavirus-1 E2 trans-activator require an N-terminal amphipathic helix-containing E2 domain.
    Haugen TH, Turek LP, Mercurio FM, Cripe TP, Olson BJ, Anderson RD, Seidl D, Karin M, Schiller J.
    EMBO J; 1988 Dec 20; 7(13):4245-53. PubMed ID: 2854060
    [Abstract] [Full Text] [Related]

  • 9. Repression of bovine papillomavirus type 1 transcription by the E1 replication protein.
    Sandler AB, Vande Pol SB, Spalholz BA.
    J Virol; 1993 Sep 20; 67(9):5079-87. PubMed ID: 8394436
    [Abstract] [Full Text] [Related]

  • 10. Control of human papillomavirus type 11 origin of replication by the E2 family of transcription regulatory proteins.
    Chiang CM, Dong G, Broker TR, Chow LT.
    J Virol; 1992 Sep 20; 66(9):5224-31. PubMed ID: 1323690
    [Abstract] [Full Text] [Related]

  • 11. Competitive binding of viral E2 protein and mammalian core-binding factor to transcriptional control sequences of human papillomavirus type 8 and bovine papillomavirus type 1.
    Schmidt HM, Steger G, Pfister H.
    J Virol; 1997 Oct 20; 71(10):8029-34. PubMed ID: 9311900
    [Abstract] [Full Text] [Related]

  • 12. Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells.
    Ishiji T, Lace MJ, Parkkinen S, Anderson RD, Haugen TH, Cripe TP, Xiao JH, Davidson I, Chambon P, Turek LP.
    EMBO J; 1992 Jun 20; 11(6):2271-81. PubMed ID: 1318197
    [Abstract] [Full Text] [Related]

  • 13. Conserved interaction of the papillomavirus E2 transcriptional activator proteins with human and yeast TFIIB proteins.
    Benson JD, Lawande R, Howley PM.
    J Virol; 1997 Oct 20; 71(10):8041-7. PubMed ID: 9311902
    [Abstract] [Full Text] [Related]

  • 14. Enhanced transcriptional activation by E2 proteins from the oncogenic human papillomaviruses.
    Kovelman R, Bilter GK, Glezer E, Tsou AY, Barbosa MS.
    J Virol; 1996 Nov 20; 70(11):7549-60. PubMed ID: 8892874
    [Abstract] [Full Text] [Related]

  • 15. An enhanced epithelial response of a papillomavirus promoter to transcriptional activators.
    Vance KW, Campo MS, Morgan IM.
    J Biol Chem; 1999 Sep 24; 274(39):27839-44. PubMed ID: 10488130
    [Abstract] [Full Text] [Related]

  • 16. Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements.
    Dong G, Broker TR, Chow LT.
    J Virol; 1994 Feb 24; 68(2):1115-27. PubMed ID: 8289341
    [Abstract] [Full Text] [Related]

  • 17. Specific in vitro interaction between papillomavirus E2 proteins and TBP-associated factors.
    Carrillo E, Garrido E, Gariglio P.
    Intervirology; 2004 Feb 24; 47(6):342-9. PubMed ID: 15564746
    [Abstract] [Full Text] [Related]

  • 18. Transactivation-competent bovine papillomavirus E2 protein is specifically required for efficient repression of human papillomavirus oncogene expression and for acute growth inhibition of cervical carcinoma cell lines.
    Goodwin EC, Naeger LK, Breiding DE, Androphy EJ, DiMaio D.
    J Virol; 1998 May 24; 72(5):3925-34. PubMed ID: 9557678
    [Abstract] [Full Text] [Related]

  • 19. Bovine papilloma virus (BPV)-encoded E2 protein enhances binding of E1 protein to the BPV replication origin.
    Seo YS, Müller F, Lusky M, Gibbs E, Kim HY, Phillips B, Hurwitz J.
    Proc Natl Acad Sci U S A; 1993 Apr 01; 90(7):2865-9. PubMed ID: 8385347
    [Abstract] [Full Text] [Related]

  • 20. Regulation of human papillomavirus type 11 enhancer and E6 promoter by activating and repressing proteins from the E2 open reading frame: functional and biochemical studies.
    Chin MT, Hirochika R, Hirochika H, Broker TR, Chow LT.
    J Virol; 1988 Aug 01; 62(8):2994-3002. PubMed ID: 2839716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.